Furthermore, intrinsic PD-L1 activates the cancer cell inflammasome pathway, which triggers the recruitment of myeloid-derived suppressor cells (MDSCs) and boosts the establishment of an immunosuppressive tumor microenvironment (TME) [115]. The gene discussed is CD274; the disease is neoplasm.